vimarsana.com

Latest Breaking News On - Matthew hummer - Page 1 : vimarsana.com

Purdue Research Foundation partners with IdentifySensors Biologics for COVID-19 technology

 E-Mail IMAGE: IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open. view more  Credit: Purdue University/Chris Adam WEST LAFAYETTE, Ind. - IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue s Discovery Park District. As the COVID pandemic was about to break around the globe, IdentifySensors, the parent company of IdentifySensors Biologics, had approached Purdue to help them develop a nanosensor designed to detect spoilage and specific pathogens in the food supply chain.

IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test for Smartphone – Consumer Electronics Net

3 months ago New electronic technology detects early and asymptomatic infections other home tests miss CLEVELAND–(BUSINESS WIRE)–#COVIDHomeTest–Nanosensor technology firm IdentifySensors Biologics has developed all new technology that detects COVID-19 RNA in saliva through newly developed electronic nanosensors, which significantly reduces error rates associated with chemical-based home tests. The company’s over-the-counter self-test, which can be performed entirely at home, is in final stages of development at Purdue University. (Purdue news release) The company is raising capital for expansion through a public offering. For details, visit the company’s Investment Page. The test – Check4-COVID™ – will require no prescription, no nasal swabs, no mailed samples or waiting in line. The test’s greatest advantage is its ability to accurately detect asymptomatic and early infections on a molecular level – a significant weakness in ho

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.